JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UBX
4526
DELISTED
Unity Biotechnology
UBX
| $53K | ﹤0.01% |
913
-181
| -17% | -$11.4K |
2018 Q2
7 quarters
|
|
|
SCTL
4527
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $53K | ﹤0.01% |
6,441
-41,330
| -87% | -$574K |
2017 Q2
11 quarters
|
|
|
HPR
4528
DELISTED
HighPoint Resources Corporation
HPR
| $53K | ﹤0.01% |
5,521
-10,107
| -65% | -$450K |
2018 Q1
8 quarters
|
|
|
ATXS
4529
DELISTED
Astria Therapeutics
ATXS
| $52K | ﹤0.01% |
2,077
-6,671
| -76% | -$207K |
2019 Q1
4 quarters
|
|
4530
Fortress Biotech
FBIO
$67.7M
| $52K | ﹤0.01% |
1,833
+1,143
| +166% | +$37.9K |
2019 Q3
2 quarters
|
|
|
GOOS
4531
Canada Goose Holdings
GOOS
$748M
| $52K | ﹤0.01% |
2,602
-42
| -2% | -$1.18K |
2017 Q2
11 quarters
|
|
|
JFIN
4532
Jiayin Group
JFIN
$68.6M
| $52K | ﹤0.01% |
+20,020
| New | +$69.7K |
2020 Q1
0 quarters
|
|
|
SI
4533
DELISTED
Silvergate Capital Corporation
SI
| $52K | ﹤0.01% |
5,450
+1,249
| +30% | +$17.7K |
2019 Q4
1 quarter
|
|
4534
Ascent Industries
ACNT
$124M
| $51K | ﹤0.01% |
5,853
-5,071
| -46% | -$61.1K |
2018 Q2
7 quarters
|
|
4535
Inspired Entertainment
INSE
$91.2M
| $51K | ﹤0.01% |
14,916
+3,376
| +29% | +$18.7K |
2019 Q2
3 quarters
|
|
4536
NewtekOne
NEWT
$323M
| $51K | ﹤0.01% |
3,865
-12,694
| -77% | -$241K |
2015 Q4
17 quarters
|
|
4537
One Stop Systems
OSS
$216M
| $51K | ﹤0.01% |
+35,221
| New | +$74.6K |
2020 Q1
0 quarters
|
|
4538
Paysign
PAYS
$803M
| $51K | ﹤0.01% |
9,984
+179
| +2% | +$1.45K |
2019 Q1
4 quarters
|
|
4539
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$121M
| $51K | ﹤0.01% |
2,004
-858
| -30% | -$30.1K |
2017 Q2
11 quarters
|
|
|
FTR
4540
DELISTED
Frontier Communications Corp.
FTR
| $51K | ﹤0.01% |
134,697
-11,500
| -8% | -$6.15K |
2013 Q2
27 quarters
|
|
|
BTAI
4541
DELISTED
BioXcel Therapeutics
BTAI
| $50K | ﹤0.01% |
139
-433
| -76% | -$156K |
2019 Q2
3 quarters
|
|
4542
VanEck Emerging Markets High Yield Bond ETF
HYEM
$507M
| $50K | ﹤0.01% |
+2,489
| New | +$56.6K |
2020 Q1
0 quarters
|
|
4543
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$374M
| $50K | ﹤0.01% |
1,259
-16
| -1% | -$814 |
2015 Q1
20 quarters
|
|
4544
Schwab US REIT ETF
SCHH
$10.5B
| $50K | ﹤0.01% |
3,014
-62,296
| -95% | -$1.33M |
2017 Q4
9 quarters
|
|
|
GHL
4545
DELISTED
Greenhill & Co., Inc.
GHL
| $50K | ﹤0.01% |
5,092
-14,813
| -74% | -$217K |
2013 Q2
27 quarters
|
|
|
INDT
4546
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
| $50K | ﹤0.01% |
1,540
-893
| -37% | -$35.5K |
2017 Q4
9 quarters
|
|
4547
Cadiz
CDZI
$324M
| $49K | ﹤0.01% |
4,202
-110
| -3% | -$1.07K |
2017 Q4
9 quarters
|
|
4548
CALL
Mercado Libre
MELI
$86B
| $49K | ﹤0.01% |
+100
| New | +$61.7K |
2020 Q1
0 quarters
|
|
|
BVH
4549
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $49K | ﹤0.01% |
4,219
+27
| +0.6% | +$459 |
2018 Q2
7 quarters
|
|
|
AMRS
4550
DELISTED
Amyris Inc.
AMRS
| $49K | ﹤0.01% |
19,091
-258,109
| -93% | -$753K |
2018 Q1
8 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.